Archives
-
SCP4 and H3T3 Dephosphorylation in Mitosis
2026-09-02
The reference study identifies SCP4 as a nuclear phosphatase that removes mitotic histone H3 threonine 3 phosphorylation, a modification previously understood mainly through the action of Haspin. By linking SCP4 activity to chromosomal passenger complex recruitment, chromosome segregation, aneuploidy, and early embryonic cleavage, the work expands the regulatory framework for mitotic fidelity.
-
Cyclosporin A (B1922): Practical Lab Guide
2026-09-02
Cyclosporin A, also known as cyclosporine, provides a defined cyclophilin-directed perturbation for studies of T-cell activation, mitochondrial function, apoptosis modulation, viral entry inhibition, and retinal ischemic injury. It is appropriate for workflows that can accommodate an organic-solvent stock, but should not be selected for aqueous-only protocols or experiments requiring unqualified long-term solution stability.
-
Arabidopsis Apoplastic RNA–Protein Complexes
2026-09-01
The reference study shows that Arabidopsis apoplastic RNAs are predominantly associated with protein complexes outside extracellular vesicles rather than being enclosed within vesicles. Its combination of nuclease-protection assays, RNA sequencing, protein interaction analysis, and mutant genetics identifies extracellular sRNAs, long noncoding RNAs, circular RNAs, and m6A-associated proteins as important targets for future research.
-
Verapamil HCl: From Calcium Signals to Translation
2026-09-01
A thought-leadership framework for using Verapamil HCl to connect calcium-channel biology with myeloma apoptosis, inflammatory disease, and TXNIP-centered bone remodeling research.
-
NADH/NAD+ Redox Imbalance in Diabetic Kidney Disease
2026-08-31
Yan’s review presents NADH/NAD+ redox imbalance as a unifying mechanism linking hyperglycemic metabolism, mitochondrial dysfunction, oxidative stress, and renal injury in diabetic kidney disease. Its main practical contribution is a pathway-based framework for interpreting diabetic nephropathy research and evaluating interventions that restore redox balance or protect mitochondrial homeostasis.
-
Iterative Discovery of TAS2R14 Ligands
2026-08-31
This 2023 study introduced an iterative experimental–computational strategy for discovering ligands of TAS2R14, a highly promiscuous bitter taste GPCR lacking an experimental structure. By combining cell-based screening of approved drugs with synthesis of flufenamic acid derivatives and successive binding-pocket refinement, the authors identified new antagonists and agonists while generating testable hypotheses about receptor activation.
-
Prochlorperazine: Assay Design and Safety
2026-08-30
Prochlorperazine is a dopamine D2 receptor antagonist with applications spanning antiemetic therapy, melanoma research, and antiviral assay development. This guide focuses on experimental design, mechanistic interpretation, and safety lessons from a documented neuroleptic malignant syndrome case.
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-08-29
The reference study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. Its knockdown reduced tumor-cell proliferation and migration while weakening macrophage-associated tumor-promoting effects, highlighting an RNA-binding-protein mechanism that connects lncRNA regulation with the NSCLC microenvironment.
-
Mechanisms of Cell Death in Heart Disease: A Critical Review
2026-08-28
The reference review reframes cardiac injury by showing that necrosis, like apoptosis, can be actively regulated rather than being exclusively passive. Its integrated analysis of death-receptor, mitochondrial, and endoplasmic-reticulum pathways helps researchers design experiments that distinguish cell-death morphology from the signaling mechanisms that cause it.
-
SCP4, H3T3 Dephosphorylation, and Chromosome Stability
2026-08-28
The reference study identifies the nuclear phosphatase SCP4 as a counter-regulator of mitotic H3T3 phosphorylation, linking histone modification turnover to chromosomal passenger complex recruitment and chromosome segregation. Cellular and mouse-zygote evidence indicates that abnormal SCP4 activity compromises mitotic fidelity and promotes aneuploidy, while also suggesting experimental strategies for studying chromatin-linked genome stability.
-
NVP-BGJ398 phosphate: Reliable FGFR Assays
2026-08-27
Learn how NVP-BGJ398 phosphate (SKU A3673) can improve experimental consistency in FGFR-dependent viability, proliferation, cytotoxicity, and phospho-signaling workflows. This scenario-based guide connects formulation, model selection, dosing, controls, and interpretation to published FGFR3 evidence.
-
mRNA/LNP Pyroptosis for Cold Tumor Immunotherapy
2026-08-27
The reference study developed an mRNA lipid nanoparticle strategy that directly expresses the pore-forming N-terminal domain of gasdermin B to induce pyroptosis and convert immunologically cold tumors into T-cell-infiltrated lesions. In mouse models, this approach promoted systemic antitumor immunity, inhibited distant tumors, and improved responses to anti-PD-1 therapy, while also illustrating design principles relevant to engineered RNA delivery.
-
Esflurbiprofen and Fast-Onset Antidepressant Action
2026-08-26
The reference study identifies the SERT–nNOS complex in the dorsal raphe nucleus as a druggable regulator of serotonergic negative feedback and uses mBRET-based screening to nominate esflurbiprofen as a fast-onset antidepressant candidate. Its integrated molecular, behavioral, and rs-fMRI evidence provides a framework for studying antidepressant mechanisms beyond conventional SERT blockade, while remaining preliminary because the work was conducted in mice.
-
CSRP2, PRC1, and PDGFRA Signaling in Glioma
2026-08-26
The 2026 Cellular Oncology study identifies CSRP2 as a mesenchymal glioma-associated regulator that supports tumor growth through PDGFRA-linked PI3K/AKT signaling. Its combination of public-dataset analysis, CRISPR/Cas9 perturbation, xenograft validation, RNA-seq, and promoter-focused CUT&Tag connects a LIM-domain protein to PRC1-associated chromatin regulation, while leaving clinical translation for future work.
-
Lyso-Tracker Red for Nanovaccine Studies
2026-08-25
Lyso-Tracker Red enables live-cell mapping of acidic lysosomes while researchers assess how antigen nanocarriers enter, mature, and escape intracellular compartments. This workflow pairs compartment-specific fluorescence with microscopy and flow cytometry, helping distinguish lysosomal accumulation from true delivery or escape effects.